MetaADEDB 2.0 @ LMMD
tetrahydrozoline
(BJORNXNYWNIWEY-UHFFFAOYSA-N)
Structure
SMILES
C1CN=C(N1)C1CCCc2c1cccc2.Cl
Molecular Formula:
C13H17ClN2
Molecular Weight:
236.740
Log P:
2.6746
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
24.39
CAS Number(s):
522-48-5
Synonym(s)
1.
tetrahydrozoline
2.
2-(1,2,3,4-tetrahydro-1-naphthyl)-2-imidazoline
3.
Berberil N
4.
Caltheon
5.
Collyrium Fresh
6.
Diabenyl T
7.
Eye-Sine
8.
Eye-Zine
9.
Murine Plus
10.
Murine Sore Eyes
11.
Ophtalmin
12.
Optazine Fresh
13.
Optigene
14.
Rhinopront
15.
Tetra-Ide
16.
Tetraclear
17.
Tetrilin
18.
Tyzine
19.
Vasopos
20.
Visine
21.
Vispring
22.
Yxin
23.
tetrahydrozoline hydrochloride
24.
tetrahydrozoline monohydrochloride
25.
tetrahydrozoline, (+-)-isomer
26.
tetrahydrozoline, (-)-isomer
27.
tetryzoline
External Link(s)
MeSHC005810
PubChem Compound657258
10648
ChEBI9492
CHEMBLCHEMBL1200413
KEGGdr:D01023
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 127US FAERS
2Eye irritationFAERS: 54US FAERS
3Product use issueFAERS: 38US FAERS
4Accidental exposure to productFAERS: 34US FAERS
5Therapeutic response unexpectedFAERS: 28US FAERS
6Product use in unapproved indicationFAERS: 26US FAERS
7Intentional product misuseFAERS: 22US FAERS
8Drug effect incompleteFAERS: 18US FAERS
9Drug ineffective for unapproved indicationFAERS: 15US FAERS
10Eye painFAERS: 12US FAERS
11Incorrect route of drug administrationFAERS: 12US FAERS
12Wrong technique in product usage processFAERS: 12US FAERS
13Expired product administeredFAERS: 11US FAERS
14MalaiseFAERS: 10US FAERS
15Burning sensationFAERS: 8US FAERS
16ErythemaFAERS: 7US FAERS
17VomitingFAERS: 7US FAERS
18Adverse eventFAERS: 6US FAERS
19HypersensitivityFAERS: 6US FAERS
20Depressed Level of ConsciousnessFAERS: 5US FAERS
21PoisoningFAERS: 5US FAERS
22Toxicity to various agentsFAERS: 5US FAERS
23Visual ImpairmentFAERS: 5US FAERS
24BlindnessFAERS: 4US FAERS
25BradycardiaFAERS: 4US FAERS
26Eye InfectionFAERS: 4US FAERS
27Incorrect dose administeredFAERS: 4US FAERS
28LethargyFAERS: 4US FAERS
29MydriasisFAERS: 4US FAERS
30Accidental exposure to product by childFAERS: 3US FAERS
31Accidental overdoseFAERS: 3US FAERS
32Intentional drug misuseFAERS: 3US FAERS
33Intentional product use issueFAERS: 3US FAERS
34SomnolenceFAERS: 3US FAERS
35Accidental drug intake by childFAERS: 2US FAERS
36AgitationFAERS: 2US FAERS
37Drug ToleranceFAERS: 2US FAERS
38Drug effect variableFAERS: 2US FAERS
39Euphoric moodFAERS: 2US FAERS
40HypotensionFAERS: 2US FAERS
41NauseaFAERS: 2US FAERS
42PainFAERS: 2US FAERS
43PhotophobiaFAERS: 2US FAERS
44Product label issueFAERS: 2US FAERS
45TremorFAERS: 2US FAERS
46Unevaluable eventFAERS: 2US FAERS
47Unintentional use for unapproved indicationFAERS: 2US FAERS
48Abdominal PainFAERS: 1US FAERS
49Ankle FractureFAERS: 1US FAERS
50Anorectal discomfortFAERS: 1US FAERS
51AstheniaFAERS: 1US FAERS
52Atrial FibrillationFAERS: 1US FAERS
53Blood pressure fluctuationFAERS: 1US FAERS
54ChillsFAERS: 1US FAERS
55Cold sweatFAERS: 1US FAERS
56DependenceFAERS: 1US FAERS
57DizzinessFAERS: 1US FAERS
58Drug DependenceFAERS: 1US FAERS
59Dry skinFAERS: 1US FAERS
60Duodenal UlcerFAERS: 1US FAERS
61DysgeusiaFAERS: 1US FAERS
62Exposure during breast feedingFAERS: 1US FAERS
63Eye BurnsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Eyelid irritationFAERS: 1US FAERS
65Eyelid painFAERS: 1US FAERS
66Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
67FatigueFAERS: 1US FAERS
68Feeling abnormalFAERS: 1US FAERS
69FlushingFAERS: 1US FAERS
70Gastric mucosal lesionFAERS: 1US FAERS
71HeadacheFAERS: 1US FAERS
72HungerFAERS: 1US FAERS
73Inappropriate affectFAERS: 1US FAERS
74Inappropriate schedule of drug administrationFAERS: 1US FAERS
75Incorrect drug administration durationFAERS: 1US FAERS
76Incorrect product storageFAERS: 1US FAERS
77Incorrect route of product administrationFAERS: 1US FAERS
78Mental status changesFAERS: 1US FAERS
79NervousnessFAERS: 1US FAERS
80Nonspecific reactionFAERS: 1US FAERS
81Ocular discomfortFAERS: 1US FAERS
82OverdoseFAERS: 1US FAERS
83PallorFAERS: 1US FAERS
84ParanoiaFAERS: 1US FAERS
85Product administered at inappropriate siteFAERS: 1US FAERS
86Product closure issueFAERS: 1US FAERS
87Product container issueFAERS: 1US FAERS
88Product formulation issueFAERS: 1US FAERS
89Product storage errorFAERS: 1US FAERS
90Rash erythematousFAERS: 1US FAERS
91Rebound effectFAERS: 1US FAERS
92Respiratory arrestFAERS: 1US FAERS
93Respiratory rateFAERS: 1US FAERS
94RestlessnessFAERS: 1US FAERS
95RetchingFAERS: 1US FAERS
96Sinus bradycardiaFAERS: 1US FAERS
97Skin reactionFAERS: 1US FAERS
98Suicide attemptFAERS: 1US FAERS
99Superficial injury of eyeFAERS: 1US FAERS
100SwellingFAERS: 1US FAERS
101SyncopeFAERS: 1US FAERS
102Thermal burnFAERS: 1US FAERS
103Urinary IncontinenceFAERS: 1US FAERS
104Vascular ruptureFAERS: 1US FAERS
105Victim of spousal abuseFAERS: 1US FAERS
106Wrong drug administeredFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.